Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists

Details for Australian Patent Application No. 2006298828 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Rogers-Evans, Mark; Schnider, Patrick; Ratni, Hasane; Grundschober, Christophe; Bissantz, Caterina

Agent Spruson & Ferguson

Pub. Number AU-B-2006298828

PCT Pub. Number WO2007/039438

Priority 05108966.2 28.09.05 EP

Filing date 18 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 1 December 2011

International Classifications

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4355 (2006.01)

A61K 31/437 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039438 Priority application(s): WO2007/039438

1 December 2011 Application Accepted

  Published as AU-B-2006298828

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298829-Oxadiazolyl pyrazolo-pyrimidines as mGluR2 antagonists

2006298827-Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents